In NSCLC cells, COX-2 activates STAT3 by inducing IL-6 expression [62] suggesting that COX-2 upregulation in JSRV Env-induced lung tumors may contribute to STAT3 activation in this model. This evidence concerns the gene PTGS2 and non-small cell lung carcinoma.